There are currently 16 ongoing clinical trials involving Down Syndrome
Of the 16 trials,4 trials are in Phase II
Furthermore, 4 trials are in Phase III
The global pharmaceutical industry is steadily developing new drugs for Down Syndrome, a Genetic Disorders. North America boasts of the highest number of ongoing clinical trials involving Down Syndrome. Asia-Pacific and Europe are among some of the other prominent regions involved in Down Syndrome-related drug trials.
Children's Oncology Group: The leading ongoing Down Syndrome-related clinical trials sponsor
Children's Oncology Group is the top sponsor for Down Syndrome-related ongoing clinical trials.
University Medical Center Utrecht, Annovis Bio Inc, CIncinnati Children's Hospital Medical Center, and Nagasaki University are a few other notable sponsors involving Down Syndrome.
A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward